BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23053478)

  • 1. Advanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channels.
    Zhao LM; Zhang W; Wang LP; Li GR; Deng XL
    Pflugers Arch; 2012 Dec; 464(6):613-21. PubMed ID: 23053478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCa3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells.
    Zhao LM; Su XL; Wang Y; Li GR; Deng XL
    Lab Invest; 2013 Feb; 93(2):159-67. PubMed ID: 23212096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II upregulates K(Ca)3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts.
    Wang LP; Wang Y; Zhao LM; Li GR; Deng XL
    Biochem Pharmacol; 2013 May; 85(10):1486-94. PubMed ID: 23500546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-mediated upregulation of K(Ca)3.1 channels promotes cell migration and proliferation in rat vascular smooth muscle.
    Su XL; Wang Y; Zhang W; Zhao LM; Li GR; Deng XL
    J Mol Cell Cardiol; 2011 Jul; 51(1):51-7. PubMed ID: 21463632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and IGF-I-dependent regulation of potassium channels by MAP kinases and PI3-kinase during eccentric cardiac hypertrophy.
    Teos LY; Zhao A; Alvin Z; Laurence GG; Li C; Haddad GE
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H1834-45. PubMed ID: 18757484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.
    Chen YS; Wang XJ; Feng W; Hua KQ
    Int J Mol Med; 2017 Oct; 40(4):987-998. PubMed ID: 28849117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crocin Improves the Endothelial Function Regulated by Kca3.1 Through ERK and Akt Signaling Pathways.
    Yang H; Li X; Liu Y; Li X; Li X; Wu M; Lv X; Chunhua C; Ding X; Zhang Y
    Cell Physiol Biochem; 2018; 46(2):765-780. PubMed ID: 29621746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
    Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
    Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells.
    Yang K; Wang XQ; He YS; Lu L; Chen QJ; Liu J; Shen WF
    Cardiovasc Diabetol; 2010 Oct; 9():66. PubMed ID: 20969783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminar shear stress upregulates endothelial Ca²⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca²⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
    Takai J; Santu A; Zheng H; Koh SD; Ohta M; Filimban LM; Lemaître V; Teraoka R; Jo H; Miura H
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H484-93. PubMed ID: 23792675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cells.
    Shiu SW; Wong Y; Tan KC
    J Atheroscler Thromb; 2012; 19(12):1083-92. PubMed ID: 22863784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast Cells.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Dinischiotu A
    PLoS One; 2016; 11(3):e0152376. PubMed ID: 27015414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling.
    Voloshenyuk TG; Landesman ES; Khoutorova E; Hart AD; Gardner JD
    Cytokine; 2011 Jul; 55(1):90-7. PubMed ID: 21498085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.
    Hu W; Li F; Mahavadi S; Murthy KS
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1310-20. PubMed ID: 19369446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
    Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
    Xie H; Lu J; Zhu Y; Meng X; Wang R
    Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
    Tong L; Smyth D; Kerr C; Catterall J; Richards CD
    Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin stimulates proliferation and migration of adult rat cardiac fibroblasts through PI3K/Akt pathway.
    Okada M; Oba Y; Yamawaki H
    Eur J Pharmacol; 2015 Mar; 750():20-6. PubMed ID: 25620135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.